Ox­i­tope Phar­ma

Ox­i­tope Phar­ma

The company is researching and developing treatments for a range of inflammatory and age-related diseases, including alzheimer’s disease, parkinson’s disease, atherosclerosis, and diabetes.
  • Edit
DateInvestorsAmountRound
-

N/A

-
*

N/A

Merger
Total Funding-

Recent News about Ox­i­tope Phar­ma

Edit

Investments by Ox­i­tope Phar­ma

Edit